Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Technologies to Distribute Proscia Digital Pathology Platform

NEW YORK – Agilent Technologies announced on Wednesday that it has entered a multiyear distribution agreement with digital pathology firm Proscia to offer its Concentriq Dx platform. 

The open platform allows for remote reviewing and analysis of whole-slide images and can integrate with other hardware and software solutions, including scanners and image analysis applications, Agilent said in a statement. Proscia's artificial intelligence-based system received CE marking under Europe's new In Vitro Diagnostic Regulation rules in June.

"This distribution agreement of Proscia's technology to Agilent's pathology customers demonstrates our continued commitment to providing pathologists with solutions to streamline and leverage the results of their image analysis, resulting in improved patient outcomes," Lou Welebob, VP and general manager of Agilent's pathology division, said in a statement. 

Financial and other terms of the deal were not disclosed.